Pharmaceuticals in Asia-Pacific

Pharmaceuticals in Asia-Pacific

Summary

Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

• The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
• The Asia-Pacific pharmaceuticals market registered revenues of $391.3 billion in 2023, representing a compound annual growth rate (CAGR) of 6.5% between 2018 and 2023.
• China dominated the Asia-Pacific pharmaceuticals market in 2023, accounting for the largest share of 41.1% in 2023.

Scope

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Asia-Pacific
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Asia-Pacific
• Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific pharmaceuticals market with five year forecasts

Reasons to Buy

• What was the size of the Asia-Pacific pharmaceuticals market by value in 2023?
• What will be the size of the Asia-Pacific pharmaceuticals market in 2028?
• What factors are affecting the strength of competition in the Asia-Pacific pharmaceuticals market?
• How has the market performed over the last five years?
• What are the main segments that make up Asia-Pacific's pharmaceuticals market?